Clinical Research Institute of Michigan – Shores Rheumatology
Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201
- Indication: COVID-19
- Enrollment Status: Enrollment Closed
- Protocol: AZ D7000C00001 “Supernova”
- Drug: AZD5156
- Sponsor: AstraZeneca
- Description: A Phase I/III Randomized, Double-blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment
